UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Open public recruiting
Unique ID issued by UMIN UMIN000038794
Receipt No. R000044231
Scientific Title A clinical study on the change of muscle strength, muscle mass, physical performances, and other parameters in perioperative esophageal cancer patients: a multicenter, single arm, prospective observational study
Date of disclosure of the study information 2019/12/06
Last modified on 2020/06/05

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title A clinical study on the change of muscle strength, muscle mass, physical performances, and other parameters in perioperative esophageal cancer patients
Acronym A clinical study on the change of muscle strength, muscle mass, physical performances, and other parameters during perioperative period
Scientific Title A clinical study on the change of muscle strength, muscle mass, physical performances, and other parameters in perioperative esophageal cancer patients: a multicenter, single arm, prospective observational study
Scientific Title:Acronym A clinical study on the change of muscle strength, muscle mass, physical performances, and other parameters in perioperative esophageal cancer patients
Region
Japan

Condition
Condition esophageal cancer
Classification by specialty
Gastrointestinal surgery
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 To confirm the change of muscle strength, muscle mass, physical performances, and other parameters during the perioperative period of esophagectomy
Basic objectives2 Others
Basic objectives -Others Observational
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes muscle strength, muscle mass, physical performances, respiratory functions, ADL, and body weight
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria (1) Patients who are scheduled to undergo esophagectomy
(2) Patients of 20 years or older at the time of informed consent
(3) Patients who can provide written informed consent
Key exclusion criteria (1) Patients with the Performance Status on the Eastern Cooperative Oncology Group of 3 or greater
(2) Patients with severe complications such as poorly-controlled diabetes, hypertension, etc.
(3) Patients with muscular diseases including active myopathy or muscular dystrophy
(4) Patients who have history of lower limb fractures within 6 months before the day of informed consent
(5) Patients who cannot keep standing or sitting, walk, and etc. due to severe disabilities or diseases (e.g., stroke with hemiparesis, myasthenia gravis, Parkinson's disease, peripheral neuropathy, intermittent claudication due to advanced peripheral vascular disease with poorly-controlled pain, spinal stenosis, or severe osteoarthritis of the knee or hip, and others)
(6) Patients who cannot continue deep breathing due to respiratory diseases
(7) Patients with chronic obstructive pulmonary disease whose severity grade is 3 or greater on the modified medical research council dyspnea scale (The 5th JRS Guidelines for the Management of Chronic Obstructive Pulmonary Disease)
(8) Pregnant and breastfeeding patients
(9) Patients who are participated in a clinical trial or clinical study and received an unapproved drug within 16 weeks before the day of informed consent
(10) Patients who are deemed unsuitable for inclusion in this study for any other reason based on assessment by the investigator or sub-investigator
Target sample size 30

Research contact person
Name of lead principal investigator
1st name Ryo
Middle name
Last name Ogawa
Organization Nagoya city university graduate school of medical sciences
Division name Gastroenterological surgery
Zip code 467-0001
Address 1 Kawasumi, Mizuho-cho, Mizuho-ku Nagoya, Japan
TEL 052-853-8226
Email r-ogawa@med.nagoya-cu.ac.jp

Public contact
Name of contact person
1st name Ryo
Middle name
Last name Ogawa
Organization Nagoya city university graduate school of medical sciences
Division name Gastroenterological surgery
Zip code 4670001
Address 1 Kawasumi, Mizuho-cho, Mizuho-ku Nagoya, Japan
TEL 052-853-8226
Homepage URL
Email r-ogawa@med.nagoya-cu.ac.jp

Sponsor
Institute Nagoya City University Graduate School of Medical Sciences
Institute
Department

Funding Source
Organization Otsuka Pharmaceutical Factory, Inc.
Organization
Division
Category of Funding Organization Profit organization
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization .
Address .
Tel 052-858-7215
Email clinical_research@med.nagoya-cu.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2019 Year 12 Month 06 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Open public recruiting
Date of protocol fixation
2019 Year 10 Month 09 Day
Date of IRB
2019 Year 11 Month 11 Day
Anticipated trial start date
2019 Year 12 Month 12 Day
Last follow-up date
2020 Year 12 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information A prospective study

Management information
Registered date
2019 Year 12 Month 05 Day
Last modified on
2020 Year 06 Month 05 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000044231

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.